ClinVar Miner

Submissions for variant NM_000030.3(AGXT):c.32C>A (p.Pro11His)

dbSNP: rs34116584
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000884267 SCV001027633 likely benign not provided 2024-01-28 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000186220 SCV001299486 uncertain significance Primary hyperoxaluria, type I 2017-04-28 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Preventiongenetics, part of Exact Sciences RCV003416113 SCV004113185 uncertain significance AGXT-related condition 2022-09-26 criteria provided, single submitter clinical testing The AGXT c.32C>A variant is predicted to result in the amino acid substitution p.Pro11His. To our knowledge, this variant has not been reported in the literature. However, a different amino acid substitution affecting the same residue (p.Pro11Arg) has been reported to impact the catalytic activity of the AGT enzyme (Williams et al. 2009. PubMed ID: 19479957). The c.32C>A (p.Pro11His) variant is reported in 0.14% of alleles in individuals of East Asian descent in gnomAD, including 2 homozygotes (http://gnomad.broadinstitute.org/variant/2-241808314-C-A). While we suspect this variant is benign, at this time we interpret its clinical significance as uncertain due to the absence of conclusive functional and genetic evidence.
Clinical Biochemistry Laboratory, Health Services Laboratory RCV000186220 SCV000239544 uncertain significance Primary hyperoxaluria, type I 2014-11-27 no assertion criteria provided in vitro

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.